Intermolecular, Inc.
IMI
IMI was delisted on the 19th of September, 2019.
24 hedge funds and large institutions have $25.3M invested in Intermolecular, Inc. in 2017 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 2 closing their positions.
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
34% more capital invested
Capital invested by funds: $19M → $25.3M (+$6.36M)
20% more funds holding
Funds holding: 20 → 24 (+4)
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$203K |
| 2 |
Renaissance Technologies
New York
|
+$126K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$77.3K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$70K |
| 5 |
BIP
Brandes Investment Partners
La Jolla,
California
|
+$45.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$580K |
| 2 |
SIM
Spark Investment Management
New York
|
-$43.3K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$27.2K |
| 4 |
GC
Guggenheim Capital
Chicago,
Illinois
|
-$11K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$5.09K |
IMI Hedge Fund Activity: Q4 2017 in Review
24 of the 4,419 institutional investors tracked by Wall St. Rank reported a position in Intermolecular, Inc. (IMI) for Q4 2017, worth a combined $25.3M — up 34% from $19M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new IMI positions and 2 closed out — a net gain of 4 holders — while 4 added to existing stakes and 6 trimmed.
The largest buyer was Essex Investment Management, opening a new position worth an estimated $203K. The largest seller was T. Rowe Price Associates, cutting an estimated $580K.
- 24 institutional investors held Intermolecular, Inc. (IMI) as of Q4 2017, up from 20 in Q3 2017.
- Funds reported $25.3M of Intermolecular, Inc. stock for Q4 2017, up 34% quarter-over-quarter.
- 6 funds opened new Intermolecular, Inc. positions in Q4 2017 and 2 closed out, a net change of +4 holders.
- The largest Intermolecular, Inc. buyer in Q4 2017 was Essex Investment Management, an estimated $203K added.
- The largest Intermolecular, Inc. seller in Q4 2017 was T. Rowe Price Associates, an estimated $580K sold.
Based on aggregated 13F filings for Q4 2017.